Related Experiment Video
Updated: Jul 26, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Other hereditary diseases and the liver
1Department of Paediatrics, Children's Hospital of The King's Daughters, Norfolk, Virginia, USA.
Bailliere'S Clinical Gastroenterology
|January 16, 1999
Summary
This chapter reviews hereditary liver diseases, excluding specific conditions covered elsewhere. Advances in molecular biology are improving understanding of cholestatic syndromes and their genetic links.
Area of Science:
- Hepatology
- Medical Genetics
- Molecular Biology
Background:
- Hereditary liver diseases encompass a range of genetic disorders affecting liver function.
- Many of these conditions manifest early in life, with some causing neonatal liver failure.
- Understanding the genetic basis is crucial for diagnosis and management.
Purpose of the Study:
- To provide an overview of hereditary liver diseases, highlighting genetic associations.
- To discuss the role of molecular biology in understanding cholestatic syndromes.
- To emphasize the importance of early recognition and management of these disorders.
Main Methods:
- Review of existing literature on hereditary liver diseases.
- Discussion of molecular biological techniques and their application to liver disorders.
- Exploration of pathogenetic mechanisms, including ductal plate malformation.
Main Results:
- Molecular biology has linked several cholestatic disorders to specific chromosomal locations.
- Characterization of the canalicular bile salt transporter (cBST) is advancing understanding of cholestasis.
- Some hereditary liver diseases share common underlying pathogenetic mechanisms.
Conclusions:
- Hereditary liver diseases are diverse, with varying genetic underpinnings.
- Advances in molecular genetics are key to unraveling complex liver disorders.
- While liver transplantation is a treatment option, it is not universally applicable.
More Related Videos
Related Concept Videos
01:35Pedigree Analysis
Overview
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...